Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Surveillance and Image-Guided Biopsy of the Esophagus Using an OFDI Capsule

NCT: NCT02422433 · ACTIVE_NOT_RECRUITING

NCT IDNCT02422433
StatusACTIVE_NOT_RECRUITING
Start Date2014-06
Completion2029-12
SponsorMassachusetts General Hospital (OTHER)
First posted
Last updated

Brief Summary

The purpose of this research is to test the feasibility, sensitivity, and specificity of the marking Optical Frequency Domain Imaging (OFDI) capsule for diagnosing Barrett's Esophagus (BE).

Frequently Asked Questions

What is Surveillance and Image-Guided Biopsy of the Esophagus Using an OFDI Capsule?

Surveillance and Image-Guided Biopsy of the Esophagus Using an OFDI Capsule is a clinical trial registered under NCT02422433. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT02422433?

The current status of NCT02422433 (Surveillance and Image-Guided Biopsy of the Esophagus Using an OFDI Capsule) is: ACTIVE_NOT_RECRUITING.

When did Surveillance and Image-Guided Biopsy of the Esophagus Using an OFDI Capsule start?

Surveillance and Image-Guided Biopsy of the Esophagus Using an OFDI Capsule started on 2014-06.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑